Patents lie at the interfacebetween technology and law. This reviewprovides a summary of four high-profile cases from 2021 in which patents in thepharmaceutical or medical space were litigated in the UK Courts. The first case is a dispute between Teva andBayer in relation to a patent for a formulation of Teva’s cancer drug,sorafenib tosylate. The second caserelates to Alcon’s patent for their glaucoma drug, Travoprost, and thealleged infringement of this patent by a number of generics companies. Thethird case concerns the validity of several patents belonging to Illuminarelating to labeled modified nucleotides and their use in DNA sequencingmethods. The final case relates to apatent for Insulet’s OmniPod® device, the first tubelessinsulin pump. The article aims to focus onthe technology behind the patents and to provide insight into how scienceinteracts with the law in the context of patent enforcement and infringement.
No takes yet. Share an insight, caveat, or question.
Crawford et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: